Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Canaccord ups Price Target to $7

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Mar 02, 2021 7:46pm

145 Views

Post# 32701515

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Canaccord ups Price Target to $7

Fred, I am not going away that easily,I have learned living in 4 different countries running businesses in all of them one has to be knowledgeable, persistent, consistent and flexible and of course a bit of luck would help.
I don't believe in limits when it comes to success.
One has to start beating competition's records and when you are done with them you carry on beating your own records meaning there is always room for progress.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale